Transitional Cell Carcinoma Unknown Status Phase 3 Trials for Pemetrexed (DB00642)

Also known as: Carcinoma, Transitional Cell / Carcinoma transitional cell / Transitional cell carcinoma (morphologic abnormality)

IndicationStatusPhase
DBCOND0031000 (Transitional Cell Carcinoma)Unknown Status3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03193788Pemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First Line Platinum-based ChemotherapyTreatment